SMO and ameloblastoma: In distinction from human ameloblastomas, where BRAF and SMO mutations are preferentially localized, respectively, to mandibular and maxillary tumors12, the canine HRAS and BRAF mutations occurred in both anatomic sites (Fig. 1e), and no canine SMO mutations were identified.